SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document
 

 

23 Sales Force Impact on Zohydro ® ER Prescribers • Pernix calls on ~76% of Zohydro ® TRx with its Sales force • The focused educational efforts of our field force has improved provider awareness • Some of the declines in Aligned Non Focus are HCPs that have moved away from Pain management for various reasons 46,674 14,203 5,350 59,336 10,994 4,390 – 10,000 20,000 30,000 40,000 50,000 60,000 Focus HCPs Aligned Non Focus White Space YTD 2017 YTD 2018 YOY TRx Performance by HCP Type (YTD as of October) HCP Type Healthcare Prescribing Professionals Focus 2,984 Aligned Non Focus (1) 4,718 White Space 1,361 Source: SHA PHAST data through October 2018 . ( 1 ) Aligned Non Focus represents HCPs that fall within sales territories, but on whom the field force does not actively focus educational efforts.